Mercaptopropionaldehyde from homocysteine: Implications for Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 12, Issue 3, 2007, Pages 241-243

  Toohey, John I ^a  

^a Cytoregulation Research   (Canada)

Author keywords

Alzheimer's disease; Amyloid diseases; Amyloid plaques; Dehydroascorbic acid; Homocysteine thiolactone

Indexed keywords

3 MERCAPTOPROPIONALDEHYDE; ALDEHYDE DERIVATIVE; DEHYDROASCORBIC ACID; HOMOCYSTEINE; THIOLACTONE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CHEMICAL STRUCTURE; MOLECULAR INTERACTION; NEUROFIBRILLARY TANGLE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; REACTION ANALYSIS; RISK FACTOR;

EID: 36549013144     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2007-12305     Document Type: Article

References (6)

1. H. Jakubowski, Pathophysiological consequences of homocysteine excess, J Nutr 136 (2006), 1741S-1749S.
2. T. Koppanyi, A.E. Vivino and F.P.Veitch, Areaction of ascorbic acid with amino acids, Science 101 (1945), 541-542.
3. T. Kurata, M. Fujimaki and Y. Sakurai, Red pigment produced by the action of dehydro-L-ascorbic acid with a-amino acid, Agr Biol Chem 37 (1973), 1471-1477.
4. H. Padh, Vitamin C: newer insights into its biochemical functions, Nutr Rev 49 (1991), 65-79.
5. B. Pecherer, The preparation of dehydro-L-ascorbic acid and its methanol complex. Some reactions of dehydro-L-ascorbic acid, J Am Chem Soc 73 (1951), 3827-3830.
6. T.B. Shea, guest editor, Folate and homocysteine in Alzheimer's Disease, Special Issue of J Alzheimer's Disease 9 (2006), 359-457.